mrd in myeloma
Published 4 years ago • 47 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:20
mrd in myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies
-
2:27
mrd by mass spectrometry in the peripheral blood in myeloma
-
3:18
what does it mean when a myeloma patient is mrd negative?
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
3:21
is there a new highly sensitive blood test to detect minimal residual disease?
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
4:40
management of r/r myeloma and mrd assessment
-
2:57
novel targeted therapies for the treatment of bpdcn
-
4:39
highlights from day 2: mrd in myeloma
-
1:15
the importance of mrd in multiple myeloma management
-
4:38
the potential of mrd-adapted treatment in multiple myeloma
-
2:09
mrd in multiple myeloma: prognosis, a clinical trial endpoint, and guiding treatment decisions
-
5:18
the value of mrd as a prognostic tool in myeloma
-
2:08
minimally invasive assessment of mrd in multiple myeloma
-
3:15
the evolution of mrd for myeloma
-
1:46
the assets of mrd in myeloma
-
1:46
mrd: the most relevant prognostic factor in myeloma
-
6:28
mrd detection in myeloma: single cell rnaseq, protein-based & vdj sequencing